
Daniel Michael Podgorski
Examiner (ID: 7354, Phone: (571)272-6270 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 339 |
| Issued Applications | 186 |
| Pending Applications | 0 |
| Abandoned Applications | 153 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12091187
[patent_doc_number] => 20170348280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'COUNTERACTING THE INHIBITION OF COLLAGEN SYNTHESIS BY SELECT CALCIUM AND SODIUM CHANNEL BLOCKERS USING ASCORBIC ACID AND ASCORBYL PALMITATE'
[patent_app_type] => utility
[patent_app_number] => 15/174352
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8364
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174352 | COUNTERACTING THE INHIBITION OF COLLAGEN SYNTHESIS BY SELECT CALCIUM AND SODIUM CHANNEL BLOCKERS USING ASCORBIC ACID AND ASCORBYL PALMITATE | Jun 5, 2016 | Abandoned |
Array
(
[id] => 11310173
[patent_doc_number] => 20160346283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'Various Compounds as Autophagy Stimulants'
[patent_app_type] => utility
[patent_app_number] => 15/167350
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10309
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15167350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/167350 | Various Compounds as Autophagy Stimulants | May 26, 2016 | Abandoned |
Array
(
[id] => 11969743
[patent_doc_number] => 20170273896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'CONTROLLED EXTENDED RELEASE PREGABALIN'
[patent_app_type] => utility
[patent_app_number] => 15/503856
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21312
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503856 | Controlled extended release pregabalin | May 25, 2016 | Issued |
Array
(
[id] => 14261251
[patent_doc_number] => 10280177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Use of polyols to obtain stable polymorphous forms of rifaximin
[patent_app_type] => utility
[patent_app_number] => 15/153636
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4079
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15153636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/153636 | Use of polyols to obtain stable polymorphous forms of rifaximin | May 11, 2016 | Issued |
Array
(
[id] => 12766114
[patent_doc_number] => 20180147206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => ACTIVATION OF NEURONAL STORE-OPERATED CALCIUM ENTRY PATHWAY FOR THE TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/572292
[patent_app_country] => US
[patent_app_date] => 2016-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572292
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/572292 | ACTIVATION OF NEURONAL STORE-OPERATED CALCIUM ENTRY PATHWAY FOR THE TREATMENT OF ALZHEIMER'S DISEASE | May 3, 2016 | Abandoned |
Array
(
[id] => 11210878
[patent_doc_number] => 09439895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients'
[patent_app_type] => utility
[patent_app_number] => 15/134807
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7840
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134807
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134807 | Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients | Apr 20, 2016 | Issued |
Array
(
[id] => 12675541
[patent_doc_number] => 20180117013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => METHODS OF TREATING LIVER DISEASE USING INDANE ACETIC ACID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/561434
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561434 | METHODS OF TREATING LIVER DISEASE USING INDANE ACETIC ACID DERIVATIVES | Mar 22, 2016 | Abandoned |
Array
(
[id] => 11962003
[patent_doc_number] => 20170266156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHOD FOR PREVENTING CANCER BY USING PHTHALIDES'
[patent_app_type] => utility
[patent_app_number] => 15/071190
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3654
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071190
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071190 | METHOD FOR PREVENTING CANCER BY USING PHTHALIDES | Mar 14, 2016 | Abandoned |
Array
(
[id] => 11025029
[patent_doc_number] => 20160221984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'MIGRASTATINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/065090
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27583
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065090
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/065090 | Migrastatins and uses thereof | Mar 8, 2016 | Issued |
Array
(
[id] => 14611535
[patent_doc_number] => 10358453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Antiviral compounds
[patent_app_type] => utility
[patent_app_number] => 15/052631
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 1
[patent_no_of_words] => 50131
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15052631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/052631 | Antiviral compounds | Feb 23, 2016 | Issued |
Array
(
[id] => 11016736
[patent_doc_number] => 20160213689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'Treatment of Pulmonary Disease'
[patent_app_type] => utility
[patent_app_number] => 15/008665
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16079
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15008665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/008665 | Treatment of Pulmonary Disease | Jan 27, 2016 | Abandoned |
Array
(
[id] => 11002403
[patent_doc_number] => 20160199352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCERS EXPRESSING MISSRII'
[patent_app_type] => utility
[patent_app_number] => 14/986865
[patent_app_country] => US
[patent_app_date] => 2016-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 32713
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14986865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/986865 | PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCERS EXPRESSING MISSRII | Jan 3, 2016 | Abandoned |
Array
(
[id] => 10760557
[patent_doc_number] => 20160106709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/985989
[patent_app_country] => US
[patent_app_date] => 2015-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28671
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985989
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/985989 | VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE | Dec 30, 2015 | Abandoned |
Array
(
[id] => 10978349
[patent_doc_number] => 20160175292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'Antioxidants Having Aromatic Structures Reacting with Superoxide'
[patent_app_type] => utility
[patent_app_number] => 14/978448
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 6347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978448
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/978448 | Antioxidants Having Aromatic Structures Reacting with Superoxide | Dec 21, 2015 | Abandoned |
Array
(
[id] => 11804450
[patent_doc_number] => 09545413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-17
[patent_title] => 'Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug'
[patent_app_type] => utility
[patent_app_number] => 14/966323
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 12095
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966323
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/966323 | Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug | Dec 10, 2015 | Issued |
Array
(
[id] => 11319320
[patent_doc_number] => 09518059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Inhibitor crystalline form and preparation method and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/956743
[patent_app_country] => US
[patent_app_date] => 2015-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 37
[patent_no_of_words] => 12739
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14956743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/956743 | Inhibitor crystalline form and preparation method and use thereof | Dec 1, 2015 | Issued |
Array
(
[id] => 13647895
[patent_doc_number] => 09850252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof
[patent_app_type] => utility
[patent_app_number] => 14/952348
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 47
[patent_no_of_words] => 12425
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14952348
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/952348 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof | Nov 24, 2015 | Issued |
Array
(
[id] => 12217444
[patent_doc_number] => 20180055803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'Methods for Treating Gout Flares'
[patent_app_type] => utility
[patent_app_number] => 14/930488
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12596
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930488
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/930488 | Methods for Treating Gout Flares | Nov 1, 2015 | Abandoned |
Array
(
[id] => 10768970
[patent_doc_number] => 20160115126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'INDOLE CARBOXAMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/921347
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82065
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14921347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/921347 | Indole carboxamide compounds | Oct 22, 2015 | Issued |
Array
(
[id] => 14338679
[patent_doc_number] => 20190151312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/517814
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517814
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517814 | HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES | Oct 7, 2015 | Abandoned |